title: How can we deal with the GERD treatment gap?
abstract: Patients experiencing heartburn and acid regurgitation despite proton pump inhibition therapy who are averse to antireflux surgery fall into what is called the gastroesophageal reflux disease (GERD) treatment gap. This gap may be potentially addressed by several endoscopic and laparoscopic techniques, including gastric bypass surgery for those patients who are obese. These novel techniques do not significantly alter the anatomy of the esophagogastric junction, minimizing short- and long-term adverse effects. This review provides an overview of the assessment of patients with refractory GERD and highlights the strengths and weaknesses of these minimally invasive therapies.
authors.affiliation: Division of Gastroenterology and Hepatology and Department of Surgery, Stanford University School of Medicine, Stanford, California. vagt@stanford.edu.
authors.forename: George
authors.initials: G
authors.lastname: Triadafilopoulos
authors.affiliation: Division of Gastroenterology and Hepatology and Department of Surgery, Stanford University School of Medicine, Stanford, California.
authors.forename: Dan
authors.initials: D
authors.lastname: Azagury
mesh_terms: D000818:Animals; D004724:Endoscopy / Q000379:methods; D004943:Esophagogastric Junction / Q000503:physiopathology / Q000601:surgery; D005764:Gastroesophageal Reflux / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D010535:Laparoscopy / Q000379:methods; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D054328:Proton Pump Inhibitors
keywords: GERD; antireflux surgery; endoscopic therapies for GERD